Matches in Wikidata for { <http://www.wikidata.org/entity/Q61939402> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q61939402 description "assaig clínic" @default.
- Q61939402 description "clinical trial" @default.
- Q61939402 description "clinical trial" @default.
- Q61939402 description "clinical trial" @default.
- Q61939402 description "clinical trial" @default.
- Q61939402 description "ensaio clínico" @default.
- Q61939402 description "ensayo clínico" @default.
- Q61939402 description "ensayu clínicu" @default.
- Q61939402 description "essai clinique" @default.
- Q61939402 description "klinisch onderzoek" @default.
- Q61939402 description "клінічне випробування" @default.
- Q61939402 description "կլինիկական փորձարկում" @default.
- Q61939402 description "临床试验" @default.
- Q61939402 name "Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)" @default.
- Q61939402 type Item @default.
- Q61939402 label "Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)" @default.
- Q61939402 prefLabel "Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)" @default.
- Q61939402 P1050 Q61939402-40DF4E3A-27F8-49A1-BB1F-687A00905323 @default.
- Q61939402 P1132 Q61939402-0D2D8925-23E1-4080-8B51-BA063DB16411 @default.
- Q61939402 P1476 Q61939402-A5E6F3E9-572C-48E0-8B2F-6D4AD4B968FD @default.
- Q61939402 P17 Q61939402-81A8D539-DE95-4B97-A2D1-AC8D2E941390 @default.
- Q61939402 P1813 Q61939402-4BD8E996-F88E-46C8-B9BF-B8B99F7A3A0E @default.
- Q61939402 P2899 Q61939402-230BBBC2-799E-4470-A2DA-1684D8CA1BA1 @default.
- Q61939402 P3098 Q61939402-599B0C8B-B016-46BF-817D-3FF00A4198DC @default.
- Q61939402 P31 Q61939402-C3E906BB-5380-406E-8AB9-C4DC1E8C00A7 @default.
- Q61939402 P4844 Q61939402-189FCBB0-1DD7-4C79-85AE-BEF79B9BC9E3 @default.
- Q61939402 P4844 Q61939402-380C4CC2-BC73-4806-8B01-5DC4D9FAEBF8 @default.
- Q61939402 P4844 Q61939402-52EBED23-4F32-4BE3-93ED-4F7D119D7A61 @default.
- Q61939402 P580 Q61939402-6D3521B1-92AD-4206-917F-CDF08399B3C1 @default.
- Q61939402 P582 Q61939402-87CE60D9-C15B-42A9-9D01-20314CB8C85D @default.
- Q61939402 P6099 Q61939402-B2E1BA0F-85A2-4EB3-8360-B8212AF673A1 @default.
- Q61939402 P6153 Q61939402-B1160A4C-4158-4816-8FA0-3E281EABE9AF @default.
- Q61939402 P8005 Q61939402-163E0007-400F-4735-98F8-8CE6D2B0773E @default.
- Q61939402 P8005 Q61939402-6F8C34FA-F5FF-430C-8EE4-B9D06D8D3A42 @default.
- Q61939402 P8363 Q61939402-D48BC6D8-6410-4D9E-94C0-2926B41F3843 @default.
- Q61939402 P859 Q61939402-215B653C-DC00-468B-B7AA-B58BB55CCA76 @default.
- Q61939402 P1050 Q179630 @default.
- Q61939402 P1132 "+28" @default.
- Q61939402 P1476 "A Phase I Trial Evaluating the Effects of Plerixafor (AMD3100) and G-CSF in Combination With Azacitidine (Vidaza) for the Treatment of MDS" @default.
- Q61939402 P17 Q30 @default.
- Q61939402 P1813 "MDS" @default.
- Q61939402 P2899 "+18" @default.
- Q61939402 P3098 "NCT01065129" @default.
- Q61939402 P31 Q30612 @default.
- Q61939402 P4844 Q416451 @default.
- Q61939402 P4844 Q6523037 @default.
- Q61939402 P4844 Q905835 @default.
- Q61939402 P580 "2010-09-02T00:00:00Z" @default.
- Q61939402 P582 "2014-07-01T00:00:00Z" @default.
- Q61939402 P6099 Q5452194 @default.
- Q61939402 P6153 Q7972509 @default.
- Q61939402 P8005 Q76651189 @default.
- Q61939402 P8363 Q78089383 @default.
- Q61939402 P859 Q7972509 @default.